12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

• SenesTech SNES shares moved upwards by 11.1% to $4.11 during Tuesday's after-market session. SenesTech's trading volume hit 206.4K shares by close, accounting for 177.0% of its average volume over the last 100 days. The company's market cap stands at $2.7 million.
• Unicycive Therapeutics UNCY shares moved upwards by 6.71% to $0.59. The market value of their outstanding shares is at $8.9 million.
• Aspira Womens Health AWH shares moved upwards by 5.26% to $0.6. The company's market cap stands at $74.7 million.
• Predictive Oncology POAI shares moved upwards by 4.99% to $0.58. The company's market cap stands at $45.4 million.
• Dyne Therapeutics DYN shares moved upwards by 4.98% to $14.75. Dyne Therapeutics's trading volume hit 216.7K shares by close, accounting for 70.8% of its average volume over the last 100 days. The company's market cap stands at $768.8 million.
• Immix Biopharma IMMX shares rose 4.87% to $3.01. The company's market cap stands at $41.9 million.

Losers

• Lixte Biotech Hldgs LIXT shares fell 10.6% to $1.69 during Tuesday's after-market session. Trading volume for this security closed at 1.0 million, accounting for 2183.3% of its average full-day volume over the last 100 days. The company's market cap stands at $28.1 million.
• Evolus EOLS stock decreased by 8.11% to $8.5. The market value of their outstanding shares is at $478.0 million.
• Celyad Oncology CYAD stock declined by 8.01% to $1.38. At the close, Celyad Oncology's trading volume reached 3.0 million shares. This is 210.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $31.1 million.
• Cardio Diagnostics Hldgs CDIO stock declined by 7.49% to $2.1. This security traded at a volume of 98.1K shares come close, making up 17.1% of its average volume over the last 100 days. The market value of their outstanding shares is at $19.9 million.
• Nymox Pharmaceutical NYMX stock fell 7.27% to $0.43. The company's market cap stands at $38.5 million.
• Processa Pharma PCSA stock declined by 7.08% to $0.81. The company's market cap stands at $12.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.